Utah Retirement Systems’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$20.8M Sell
864,528
-59,116
-6% -$1.55M 0.2% 85
2026
Q1
$25.9M Sell
923,644
-14,980
-2% -$399K 0.27% 66
2025
Q4
$23.4M Sell
938,624
-92
-0% -$2.32K 0.22% 82
2025
Q3
$23.9M Buy
938,716
+3,439
+0.4% +$84.9K 0.23% 80
2025
Q2
$22.7M Sell
935,277
-3,707
-0.4% -$86.5K 0.24% 80
2025
Q1
$23.8M Sell
938,984
-1,584
-0.2% -$41.4K 0.27% 68
2024
Q4
$25M Buy
940,568
+2,800
+0.3% +$75.9K 0.27% 63
2024
Q3
$27.1M Buy
937,768
+3,500
+0.4% +$102K 0.31% 58
2024
Q2
$26.1M Sell
934,268
-45,400
-5% -$1.25M 0.31% 55
2024
Q1
$27.2M Sell
979,668
-700
-0.1% -$19.4K 0.32% 56
2023
Q4
$28.2M Buy
980,368
+5,800
+0.6% +$175K 0.36% 47
2023
Q3
$32.3M Buy
974,568
+4,400
+0.5% +$156K 0.46% 35
2023
Q2
$35.6M Sell
970,168
-36,900
-4% -$1.44M 0.49% 30
2023
Q1
$41.1M Buy
1,007,068
+3,100
+0.3% +$134K 0.59% 25
2022
Q4
$51.4M Sell
1,003,968
-9,400
-0.9% -$451K 0.82% 19
2022
Q3
$44.3M Buy
1,013,368
+5,000
+0.5% +$243K 0.74% 19
2022
Q2
$52.9M Buy
1,008,368
+11,800
+1% +$601K 0.85% 16
2022
Q1
$51.6M Sell
996,568
-16,500
-2% -$856K 0.69% 20
2021
Q4
$59.8M Buy
1,013,068
+2,300
+0.2% +$114K 0.74% 16
2021
Q3
$43.5M Sell
1,010,768
-53,600
-5% -$2.37M 0.59% 25
2021
Q2
$41.7M Sell
1,064,368
-4,100
-0.4% -$159K 0.54% 27
2021
Q1
$38.7M Sell
1,068,468
-46,900
-4% -$1.67M 0.54% 31
2020
Q4
$41.1M Sell
1,115,368
-9,954
-0.9% -$365K 0.58% 28
2020
Q3
$39.2M Buy
1,125,322
+7,589
+0.7% +$266K 0.65% 26
2020
Q2
$34.7M Sell
1,117,733
-1,265
-0.1% -$43K 0.64% 28
2020
Q1
$34.7M Sell
1,118,998
-211
-0% -$7.19K 0.75% 20
2019
Q4
$41.6M Buy
1,119,209
+4,005
+0.4% +$143K 0.73% 23
2019
Q3
$38M Sell
1,115,204
-2,740
-0.2% -$99.6K 0.72% 28
2019
Q2
$45.9M Sell
1,117,944
-23,960
-2% -$951K 0.88% 17
2019
Q1
$46M Buy
1,141,904
+1,378
+0.1% +$55.2K 0.91% 16
2018
Q4
$47.2M Buy
1,140,526
+2,635
+0.2% +$109K 1.07% 11
2018
Q3
$47.6M Buy
1,137,891
+5,059
+0.4% +$195K 0.92% 13
2018
Q2
$39M Sell
1,132,832
-29,512
-3% -$1.01M 0.81% 19
2018
Q1
$39.1M Buy
1,162,344
+1,792
+0.2% +$61.6K 0.83% 19
2017
Q4
$39.9M Buy
1,160,552
+15,705
+1% +$536K 0.84% 19
2017
Q3
$38.8M Buy
1,144,847
+1,475
+0.1% +$47.4K 0.87% 16
2017
Q2
$36.4M Sell
1,143,372
-18,550
-2% -$585K 0.85% 16
2017
Q1
$37.7M Buy
1,161,922
+1,265
+0.1% +$39.9K 0.9% 16
2016
Q4
$35.8M Hold
1,160,657
0.9% 18
2016
Q3
$37.3M Buy
1,160,657
+210
+0% +$7.02K 0.97% 15
2016
Q2
$38.8M Sell
1,160,447
-8,115
-0.7% -$259K 1.03% 14
2016
Q1
$32.9M Buy
1,168,562
+4,321
+0.4% +$123K 0.89% 16
2015
Q4
$35.7M Buy
1,164,241
+2,003
+0.2% +$63K 0.97% 15
2015
Q3
$34.6M Buy
1,162,238
+6,324
+0.5% +$203K 0.99% 14
2015
Q2
$36.8M Sell
1,155,914
-46,166
-4% -$1.5M 0.98% 11
2015
Q1
$39.7M Buy
1,202,080
+38,366
+3% +$1.22M 1.04% 10
2014
Q4
$34.4M Hold
1,163,714
0.95% 12
2014
Q3
$32.6M Sell
1,163,714
-2,635
-0.2% -$74K 0.94% 13
2014
Q2
$32.8M Sell
1,166,349
-99,814
-8% -$2.85M 0.94% 13
2014
Q1
$38.6M Buy
1,266,163
+8,959
+0.7% +$267K 1.11% 12
2013
Q4
$36.5M Hold
1,257,204
1.08% 12
2013
Q3
$34.2M Sell
1,257,204
-10,751
-0.8% -$293K 1.11% 13
2013
Q2
$33.7M Buy
+1,267,955
New +$35M 1.14% 14

Other funds holding PFE

Utah Retirement Systems's PFE Position: Q2 2026 in Review

Utah Retirement Systems reduced its Pfizer (PFE) stake by 6.4% in Q2 2026, selling an estimated $1.55M and leaving 864,528 shares worth $20.8M. The position accounts for 0.2% of the portfolio, ranked #85.

Utah Retirement Systems first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $59.8M in Q4 2021. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Utah Retirement Systems held 864,528 shares of Pfizer worth $20.8M as of Q2 2026.
  • Utah Retirement Systems sold 59,116 Pfizer shares in Q2 2026, an estimated $1.55M.
  • Pfizer made up 0.2% of Utah Retirement Systems's portfolio in Q2 2026, its #85 holding.
  • Utah Retirement Systems first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
  • Utah Retirement Systems's Pfizer position peaked at $59.8M in Q4 2021.
  • 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Utah Retirement Systems's 13F filing for Q2 2026, filed 14 Aug 2026.